12.85
-1.00
(-7.22%)
At close: January 10 at 3:59:54 PM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-99,812.00
-68,908.00
-47,431.00
-45,207.00
-19,027.00
Investing Cash Flow
6,666.00
6,922.00
-3,309.00
-770.00
-1,189.00
Financing Cash Flow
229,998.00
254,507.00
13,564.00
35,777.00
82,725.00
End Cash Position
154,970.00
208,992.00
16,633.00
53,641.00
64,026.00
Capital Expenditure
-966.00
-710.00
-3,309.00
-520.00
-231.00
Issuance of Capital Stock
230,696.00
254,600.00
13,202.00
31,507.00
76,236.00
Repayment of Debt
-325.00
-149.00
--
--
--
Free Cash Flow
-100,778.00
-69,618.00
-50,740.00
-45,727.00
-19,258.00
3/31/2021 - 11/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDMA.CN Pharmala Biotech Holdings Inc.
0.3100
+16.98%
PHRM.CN PharmaTher Holdings Ltd.
0.2150
-6.52%
ATAI Atai Life Sciences N.V.
1.5000
-7.41%
MNMD Mind Medicine (MindMed) Inc.
6.93
-1.98%
GHRS GH Research PLC
8.57
-4.57%
LOBE.CN Lobe Sciences Ltd.
0.0250
0.00%
DRUG.CN Bright Minds Biosciences Inc.
56.00
-3.25%
EDSA Edesa Biotech, Inc.
1.7750
-1.39%
TYP.AX TRYPTAMINE FPO [TYP]
0.0370
-5.13%
ENBI.CN Entheon Biomedical Corp.
0.2750
+7.84%